حسن سجواني Hassan Sajwani (@Sajwani)

두바이에서 열린 세계정부정상회의(World Gov Summit)에서 데이비드 싱클레어(David Sinclair)가 올해 안에 노화가 가역적인지 여부를 확인하게 될 것이라고 발표했다. 그의 연구팀은 동물의 생물학적 나이를 6주 만에 75%까지 되돌리는 데 성공했으며, FDA가 최초의 인간 실험을 승인했다고 한다. 이는 노화 역전 연구의 중대한 진전으로 평가된다.

https://x.com/Sajwani/status/2026045732269248604

#longevity #biotech #aging #research #humantrial

حسن سجواني 🇦🇪 Hassan Sajwani (@Sajwani) on X

This year at World Gov Summit in Dubai 🇦🇪 David Sinclair announced that we’ll find out this year whether aging is reversible. @davidasinclair’s lab reversed biological age in animals by 75% in just 6 weeks. The FDA has cleared the first human trial. h/t @vitrupo

X (formerly Twitter)
In First Human Trial, Zombie Cancer Cells Train the Body to Fight Tumors

A small trial is testing a decades-old method that transforms cancer cells into a "vaccine" to prevent recurrence.

SingularityHub
Pig Lung Transplanted Into a Human in Major Scientific First

A genetically modified pig lung transplanted into a brain-dead human patient functioned for nine days in a new achievement that reveals both the promise and significant challenges of xenotransplantation.

ScienceAlert
Common supplement reverses premature aging in landmark human trial

A rare genetic disorder called Werner syndrome causes premature aging and devastating health complications from an early age, yet treatment options have been lacking. New hope emerges from Chiba University, where researchers conducted the first clinical trial using nicotinamide riboside (NR), a precursor to NAD+ that s been linked to anti-aging effects. The double-blind trial revealed that NR not only safely boosted NAD+ levels but also improved cardiovascular health, reduced skin ulcers, and helped protect kidney function in patients.

ScienceDaily
Tick-killing pill shows promising results in human trial

Should it pan out, the pill would be a new weapon against Lyme disease.

Ars Technica
'Cancer-killing pill' that appears to 'annihilate' solid tumours is now being tested on humans

Sky